Cargando…
PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine
Autores principales: | Watanabe, Takashi, Akiyama, Kazufumi, Aoki, Akiko, Hayashi, Yuki, Inoue, Yoshimasa, Ishiguro, Shin, Kato, Kazuko, Pierce, Jason, Shimoda, Kazutaka, Shinozaki, Masataka, Tsuchimine, Shoko, Ueda, Mikito, Yasui-Furukori, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616808/ http://dx.doi.org/10.1093/ijnp/pyw043.213 |
Ejemplares similares
-
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki, Akiko, et al.
Publicado: (2014) -
Early Improvement and Marriage Are Determinants of the 12-Month Treatment Outcome of Paroxetine in Outpatients with Panic Disorder
por: Watanabe, Takashi, et al.
Publicado: (2017) -
Mirtazapine for Refractory Gastroparesis
por: Marella, Hemnishil K., et al.
Publicado: (2019) -
Genetic Polymorphism of 1019C/G (rs6295) Promoter of Serotonin 1A Receptor and Catechol-O-Methyltransferase in Panic Disorder
por: Watanabe, Takashi, et al.
Publicado: (2017) -
Mirtazapine withdrawal-induced mania
por: Verma, Jitendra Kumar, et al.
Publicado: (2015)